Pilot project: early access in the EU
A new pilot project under the European drug agency EMA seeks to establish a dialogue with companies concerning the prospect of early approval of drugs for a limited number of patients, Steffen Thirstrup informs.
by Henrik Tüchsen
While the UK is on the verge of introducing a new scheme to ensure early access to medicine for patients with debilitating or life-threatening diseases, the EU is working on a program along the same lines, according to Steffen Thirstrup, former head of medicines approvals in Denmark and current advisor for the major European consultant firm, NDA.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Thirstrup: EMA more welcoming towards the industry
For abonnenter
